Viruses as Therapeutic Agents for Cancer
Series: Advances in Cancer Research; 171;
- Publisher's listprice EUR 122.00
-
47 653 Ft (45 384 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 9 531 Ft off)
- Discounted price 38 123 Ft (36 307 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
47 653 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 September 2026
- ISBN 9780443432361
- Binding Hardback
- No. of pages258 pages
- Size 229x152 mm
- Weight 450 g
- Language English 0
Categories
Long description:
Viruses as Therapeutic Agents for Cancer, Volume 171 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Coxsackievirus virotherapy, Oncolytic reovirus, Cancer immunotherapy with oncolytic myxoma virus, Zika Virus as an Oncolytic Therapy, Nonreplicative adenoviral vectors for cancer, VSV Oncolytic Virotherapy, AAV vectors for cancer gene therapy, Adenovirus cancer vaccines, Advancing Clinical Translation of Oncolytic Adenoviruses, and Immunotherapuetic Cancer Terminator Viruses.
MoreTable of Contents:
1. Coxsackievirus virotherapy
Vinod E. Nambudiri
2. Oncolytic reovirus
Kenny Voon and Zhen Yun Siew
3. Cancer immunotherapy with oncolytic myxoma virus
Masmudur M. Raham, Jacqueline Carmona and Deon Nguyen
4. Zika Virus as an Oncolytic Therapy
Eric Hawley and Milan Chheda
5. Nonreplicative adenoviral vectors for cancer
Bryan E. Strauss, Ana Laura Vieira Alves, Bianca Naomi Niitsuma, Fernanda Antunes, Jean Carlos dos Santos da Luz, Mariana Barbosa de Souza and Soraia Barbosa de Oliveira
6. VSV Oncolytic Virotherapy
Jennifer Altomonte
7. AAV vectors for cancer gene therapy
Myungeun Lee, Jinhyun Park and Ji Hoon Park
8. Adenovirus cancer vaccines
Vinnycius Pereira Almeida
9. Advancing Clinical Translation of Oncolytic Adenoviruses
Julia Davydova and Margarita Romanenko
10. Immunotherapuetic Cancer Terminator Viruses
Paul B. Fisher
